439
Views
17
CrossRef citations to date
0
Altmetric
Original

RF ablation with adjuvant therapy: Comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model

, , , , &
Pages 560-567 | Received 08 Nov 2007, Accepted 19 Mar 2008, Published online: 09 Jul 2009
 

Abstract

Purpose: To determine the critical thermal dosimetry and relative efficacy for RF ablation combined with external beam radiation (XRT) or liposomal doxorubicin (LD), in an animal tumor model.

Materials and methods: This study was performed in two phases, in 13–18 mm diameter R3230 tumors subcutaneously implanted into Fischer rats. In phase 1, tumors (n = 30) were randomized into six groups. RF energy (titrated to 70°C tip temperature) was applied for either 2.5 or 5 min (n = 15, each group). For each duration, one of three adjuvant therapies was applied (n = 5, each): no therapy (control), LD (1 mg intravenously, 30 min post-RF), or XRT (20 Gy at 1 Gy min−1, within 2 h post-RF), with sacrifice at 48 h for pathologic analysis. In phase 2, thermal mapping was performed in 20 tumors throughout RF application (70°C; 5 min), at 1.5–7 mm distances from the active electrode tip. Temperature profiles throughout the tumor were constructed and were used to interpolate temperatures over time at the critical ablation margin, to derive maximum threshold temperature, AUC (area under the curve) and CEM43 (cumulative equivalent minutes at 43°C). Ablation sizes and all calculated values were compared within and across experimental groups using MANOVA statistics with pair-wise T-test for individual comparisons.

Results: RF/XRT produced the largest coagulation (11.7 ± 1.5 mm at 2.5 min, ≥15 ± 0.7 mm at 5 min), followed by RF/LD, and then RF alone (p < 0.001 for all comparisons). RF/XRT demonstrated temperature threshold decreases from RF alone of 11.7 ± 0.01°C and 12.7 ± 0.38°C at 2.5 and 5 min respectively (with absolute thresholds of 42°C for XRT compared to 52°C for RF alone). RF/LD had decreases of 4.0°C at 2.5 min and 4.4°C at 5 min. Thermal dose requirements (AUC) decreased by 7.79% or 9.28% for RF/LD compared to ≥19.36% or 25.82% for RF/XRT at 2.5 and 5 min (p < 0.001). CEM43 values followed similar patterns (p < 0.001), but with a reduction of 101 and 104 in magnitude for RF/LD and RF/XRT therapies at 5 min, respectively.

Conclusions: For a standardized RF dose, the combination of high dose XRT and RF increased ablation size compared to RF and liposomal doxorubicin or RF alone. Increased ablation size is more closely associated with decreased temperature threshold necessary to induce coagulation, rather than the total thermal dose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.